Literature DB >> 4855544

Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator.

P A Ward, J L Berenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4855544     DOI: 10.1056/NEJM197401102900203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  38 in total

1.  Characterization of the protease activity in the chemotactic factor inactivator.

Authors:  P A Ward; J Ozols
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 2.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

3.  Impaired neutrophil function in intestinal lymphangiectasia.

Authors:  R P Bolton; K L Cotter; M S Losowsky
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

4.  Monocyte production in Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  G Meuret; E Schmitt; S Tseleni; M Widmer
Journal:  Blut       Date:  1978-10-13

5.  Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment.

Authors:  C Zielinski; H Pehamberger; A T Endler; W Knapp
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

6.  In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease.

Authors:  S H Saverymuttu; A M Peters; J P Lavender; V S Chadwick; H J Hodgson
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

7.  Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis.

Authors:  D H Goddard; A P Kirk; J R Kirwan; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

8.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma.

Authors:  H Nielsen; J Bennedsen; S O Larsen; P Dombernowsky; K Viskum
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

10.  Serum stimulatory activity and polymorphonuclear leucocyte movement in patients with fulminant hepatic failure.

Authors:  R J Wyke; A G Yousif-Kadaru; I A Rajkovic; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.